Therapeutic targeting of the pathological triad of extrasynaptic NMDA receptor signaling in neurodegenerations
Activation of extrasynaptic N-methyl-d-aspartate (NMDA) receptors causes neurodegeneration and cell death. The disease mechanism involves a pathological triad consisting of mitochondrial dysfunction, loss of integrity of neuronal structures and connectivity, and disruption of excitation-transcriptio...
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2017
|
| In: |
Journal of experimental medicine
Year: 2017, Jahrgang: 214, Heft: 3, Pages: 569-578 |
| ISSN: | 1540-9538 |
| DOI: | 10.1084/jem.20161673 |
| Online-Zugang: | Verlag, Volltext: http://dx.doi.org/10.1084/jem.20161673 Verlag, Volltext: http://jem.rupress.org/content/214/3/569 
|
| Verfasserangaben: | Hilmar Bading |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 157690315X | ||
| 003 | DE-627 | ||
| 005 | 20220814175650.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180627s2017 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1084/jem.20161673 |2 doi | |
| 035 | |a (DE-627)157690315X | ||
| 035 | |a (DE-576)50690315X | ||
| 035 | |a (DE-599)BSZ50690315X | ||
| 035 | |a (OCoLC)1341012971 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 32 |2 sdnb | ||
| 100 | 1 | |a Bading, Hilmar |d 1958- |e VerfasserIn |0 (DE-588)1017989680 |0 (DE-627)690486553 |0 (DE-576)170837947 |4 aut | |
| 245 | 1 | 0 | |a Therapeutic targeting of the pathological triad of extrasynaptic NMDA receptor signaling in neurodegenerations |c Hilmar Bading |
| 264 | 1 | |c 2017 | |
| 300 | |a 10 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Published February 16, 2017 | ||
| 500 | |a Published online: 16 February, 2017 | ||
| 500 | |a Gesehen am 27.06.2018 | ||
| 520 | |a Activation of extrasynaptic N-methyl-d-aspartate (NMDA) receptors causes neurodegeneration and cell death. The disease mechanism involves a pathological triad consisting of mitochondrial dysfunction, loss of integrity of neuronal structures and connectivity, and disruption of excitation-transcription coupling caused by CREB (cyclic adenosine monophosphate-responsive element-binding protein) shut-off and nuclear accumulation of class IIa histone deacetylases. Interdependency within the triad fuels an accelerating disease progression that culminates in failure of mitochondrial energy production and cell loss. Both acute and slowly progressive neurodegenerative conditions, including stroke, Alzheimer’s disease, amyotrophic lateral sclerosis, and Huntington’s disease, share increased death signaling by extrasynaptic NMDA receptors caused by elevated extracellular glutamate concentrations or relocalization of NMDA receptors to extrasynaptic sites. Six areas of therapeutic objectives are defined, based on which a broadly applicable combination therapy is proposed to combat the pathological triad of extrasynaptic NMDA receptor signaling that is common to many neurodegenerative diseases. | ||
| 773 | 0 | 8 | |i Enthalten in |t Journal of experimental medicine |d New York, NY : Rockefeller Univ. Press, 1896 |g 214(2017), 3, Seite 569-578 |h Online-Ressource |w (DE-627)270425594 |w (DE-600)1477240-1 |w (DE-576)078590167 |x 1540-9538 |7 nnas |a Therapeutic targeting of the pathological triad of extrasynaptic NMDA receptor signaling in neurodegenerations |
| 773 | 1 | 8 | |g volume:214 |g year:2017 |g number:3 |g pages:569-578 |g extent:10 |a Therapeutic targeting of the pathological triad of extrasynaptic NMDA receptor signaling in neurodegenerations |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1084/jem.20161673 |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u http://jem.rupress.org/content/214/3/569 |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20180627 | ||
| 993 | |a Article | ||
| 994 | |a 2017 | ||
| 998 | |g 1017989680 |a Bading, Hilmar |m 1017989680:Bading, Hilmar |d 700000 |d 712000 |d 712100 |d 700000 |d 718000 |e 700000PB1017989680 |e 712000PB1017989680 |e 712100PB1017989680 |e 700000PB1017989680 |e 718000PB1017989680 |k 0/700000/ |k 1/700000/712000/ |k 2/700000/712000/712100/ |k 0/700000/ |k 1/700000/718000/ |p 1 |x j |y j | ||
| 999 | |a KXP-PPN157690315X |e 3013889217 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"recId":"157690315X","physDesc":[{"extent":"10 S."}],"origin":[{"dateIssuedKey":"2017","dateIssuedDisp":"2017"}],"relHost":[{"titleAlt":[{"title":"JEM"}],"pubHistory":["1.1896 -"],"id":{"zdb":["1477240-1"],"eki":["270425594"],"issn":["1540-9538"]},"part":{"volume":"214","year":"2017","issue":"3","text":"214(2017), 3, Seite 569-578","extent":"10","pages":"569-578"},"physDesc":[{"extent":"Online-Ressource"}],"recId":"270425594","disp":"Therapeutic targeting of the pathological triad of extrasynaptic NMDA receptor signaling in neurodegenerationsJournal of experimental medicine","origin":[{"dateIssuedKey":"1896","dateIssuedDisp":"1896-","publisherPlace":"New York, NY","publisher":"Rockefeller Univ. Press"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"language":["eng"],"note":["Gesehen am 22.10.08"],"title":[{"subtitle":"JEM","title_sort":"Journal of experimental medicine","title":"Journal of experimental medicine"}]}],"person":[{"family":"Bading","given":"Hilmar","role":"aut","display":"Bading, Hilmar"}],"title":[{"title":"Therapeutic targeting of the pathological triad of extrasynaptic NMDA receptor signaling in neurodegenerations","title_sort":"Therapeutic targeting of the pathological triad of extrasynaptic NMDA receptor signaling in neurodegenerations"}],"language":["eng"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"note":["Published February 16, 2017","Published online: 16 February, 2017","Gesehen am 27.06.2018"],"name":{"displayForm":["Hilmar Bading"]},"id":{"eki":["157690315X"],"doi":["10.1084/jem.20161673"]}} | ||
| SRT | |a BADINGHILMTHERAPEUTI2017 | ||